SYNE1 and breast cancer: SYNE1 was implicated in many cancers and gene expression profiles analysis in TCGA displayed that SYNE1 was downregulated in 18 cancer types, including NSCLC, breast cancer and colon cancer, etc, compared with normal tissues [32].